A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma.
Siegel AB, Narayan R, Rodriguez R, Goyal A, Jacobson JS, Kelly K, Ladas E, Lunghofer PJ, Hansen RJ, Gustafson DL, Flaig TW, Tsai WY, Wu DP, Lee V, Greenlee H.
Siegel AB, et al. Among authors: jacobson js.
Integr Cancer Ther. 2014 Jan;13(1):46-53. doi: 10.1177/1534735413490798. Epub 2013 Jun 11.
Integr Cancer Ther. 2014.
PMID: 23757319
Free PMC article.
Clinical Trial.